“Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer” – Letter

Por Cardnell, Robert JG, Byers, Lauren A.
Publicado em 2014

Smoking, p53 Mutation, and Lung Cancer

Por Gibbons, Don L., Byers, Lauren A., Kurie, Jonathan M.
Publicado em 2014

Progress in the Management of Limited-Stage Small Cell Lung Cancer

Por Amini, Arya, Byers, Lauren A., Welsh, James W., Komaki, Ritsuko
Publicado em 2013

Beyond chemotherapy - emerging biomarkers and therapies as SCLC enters the immune checkpoint era

Por Della Corte, Carminia M., Gay, Carl M., Byers, Lauren A.
Publicado no Cancer (2019)

Using Reverse-Phase Protein Arrays (RPPAs) as Pharmacodynamic Assays for Functional Proteomics, Biomarker Discovery, and Drug Development in Cancer

Por Lu, Yiling, Ling, Shiyun, Hegde, Apurva M., Byers, Lauren A., Coombes, Kevin, Mills, Gordon B., Akbani, Rehan
Publicado no Semin Oncol (2016)

Sequencing of Mutational Hotspots in Cancer-Related Genes in Small Cell Neuroendocrine Cervical Cancer

Por Frumovitz, Michael, Burzawa, Jennifer K., Byers, Lauren A., Lyons, Yasmin A., Ramalingam, Preetha, Coleman, Robert C., Brown, Jubilee
Publicado no Gynecol Oncol (2016)

Prognostic Significance of Pretreatment Total Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio in Extensive-Stage Small-Cell Lung Cancer

Por Suzuki, Ryoko, Lin, Steven H., Wei, Xiong, Allen, Pamela K., Welsh, James W., Byers, Lauren A., Komaki, Ritsuko
Publicado no Radiother Oncol (2018)

Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus

Por James, Michael A., Wen, Weidong, Wang, Yian, Byers, Lauren A., Heymach, John V., Coombes, Kevin R., Girard, Luc, Minna, John, You, Ming
Publicado em 2012

The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers

Por Kundu, Samrat T., Byers, Lauren A., Peng, David, Roybal, Jonathon D., Diao, Lixia, Wang, Jing, Tong, Pan, Creighton, Chad J., Gibbons, Don L.
Publicado no Oncogene (2015)

drexplorer: A tool to explore dose–response relationships and drug–drug interactions

Por Tong, Pan, Coombes, Kevin R., Johnson, Faye M., Byers, Lauren A., Diao, Lixia, Liu, Diane D., Lee, J. Jack, Heymach, John V., Wang, Jing
Publicado no Bioinformatics (2015)

Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations

Por Peng, Shaohua, Sen, Banibrata, Mazumdar, Tuhina, Byers, Lauren A., Diao, Lixia, Wang, Jing, Tong, Pan, Giri, Uma, Heymach, John V., Kadara, Humam N., Johnson, Faye M.
Publicado no Oncotarget (2015)

Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer

Por Cardnell, Robert, J, Feng, Ying, Diao, Lixia, Fan, You-Hong, Masrorpour, Fatemah, Wang, Jing, Shen, Yuqiao, Mills, Gordon, B, Minna, John, D, Heymach, John, V, Byers, Lauren, A
Publicado em 2013

Differential Sensitivity Analysis for Resistant Malignancies (DISARM) identifies common candidate therapies across platinum-resistant cancers

Por Gay, Carl M., Tong, Pan, Cardnell, Robert J., Sen, Triparna, Su, Xiao, Ma, Jun, Bara, Rasha O., Johnson, Faye M., Wakefield, Chris, Heymach, John V., Wang, Jing, Byers, Lauren A.
Publicado no Clin Cancer Res (2018)

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

Por Cardnell, Robert J., Feng, Ying, Mukherjee, Seema, Diao, Lixia, Tong, Pan, Stewart, C. Allison, Masrorpour, Fatemeh, Fan, YouHong, Nilsson, Monique, Shen, Yuqiao, Heymach, John V., Wang, Jing, Byers, Lauren A.
Publicado no PLoS One (2016)

An integrated molecular analysis of lung adenocarcinomas identifies potential therapeutic targets among TTF1-negative tumors including DNA repair proteins and Nrf2

Por Cardnell, Robert J.G., Behrens, Carmen, Diao, Lixia, Fan, YouHong, Tang, Ximing, Tong, Pan, John D., Minna, Mills, Gordon B., Heymach, John V., Wistuba, Ignacio I., Wang, Jing, Byers., Lauren A.
Publicado no Clin Cancer Res (2015)

A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma

Por Mazumdar, Tuhina, Byers, Lauren A., Shing Ng, Patrick Kwok, Mills, Gordon B., Peng, Shaohua, Diao, Lixia, Fan, You-Hong, Stemke-Hale, Katherine, Heymach, John V., Myers, Jeffrey N., Glisson, Bonnie S., Johnson, Faye M.
Publicado no Mol Cancer Ther (2014)

Blasted Cell Line Names

Por Wang, Jing, Byers, Lauren A., Yordy, John S., Liu, Wenbin, Shen, Li, Baggerly, Keith A., Giri, Uma, Myers, Jeffrey N., Ang, K. Kian, Story, Michael D., Girard, Luc, Minna, John D., Heymach, John V., Coombes, Kevin R.
Publicado em 2010

Management of the node-positive neck in the patient with HPV-associated oropharyngeal cancer

Por Garden, Adam S., Gunn, Gary B., Hessel, Amy, Beadle, Beth M., Ahmed, Salmaan, El-naggar, Adel, Fuller, Clifton D., Byers, Lauren A., Phan, Jack, Frank, Steven J., Morrison, William H., Kies, Merill S., Rosenthal, David I., Sturgis, Erich M.
Publicado em 2014

Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarc...

Por Lou, Yanyan, Diao, Lixia, Cuentas, Edwin Roger Parra, Denning, Warren L., Chen, Limo, Fan, Youhong, Byers, Lauren A., Wang, Jing, Papadimitrakopoulou, Vassiliki, Behrens, Carmen, Rodriguez, Jaime Canales, Hwu, Patrick, Wistuba, Ignacio I., Heymach, John V., Gibbons, Don L.
Publicado no Clin Cancer Res (2016)

Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer

Por Kakumu, Tomohiko, Sato, Mitsuo, Goto, Daiki, Kato, Toshio, Yogo, Naoyuki, Hase, Tetsunari, Morise, Masahiro, Fukui, Takayuki, Yokoi, Kohei, Sekido, Yoshitaka, Girard, Luc, Minna, John D., Byers, Lauren A., Heymach, John V., Coombes, Kevin R., Kondo, Masashi, Hasegawa, Yoshinori
Publicado no Cancer Sci (2017)